Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial (Q38867466)
Jump to navigation
Jump to search
scientific article published on 25 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial |
scientific article published on 25 July 2017 |
Statements
1 reference
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial (English)
1 reference
Raphael Gottardo
1 reference
Mariola Fotin-Mleczek
1 reference
Ingmar Hoerr
1 reference
Ulrike Gnad-Vogt
1 reference
Martin Alberer
1 reference
Henoch Sangjoon Hong
1 reference
Keyvan Tadjalli Mehr
1 reference
Linus Backert
1 reference
Greg Finak
1 reference
Mihai Alexandru Bica
1 reference
Aurelio Garofano
1 reference
Sven Dominik Koch
1 reference
Ralf Clemens
1 reference
25 July 2017
1 reference
1 reference
Identifiers
1 reference
1 reference